Wednesday, December 14, 2016

BRIEF-Kiadis Pharma announces initiation of Phase I/II clinical trial with ATIR201for thalassemia

* Kiadis Pharma announces initiation of a Phase I/II

clinical trial with ATIR201for thalassemia

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)